GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
F

FutureWorld FWDG · USD

N/A · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 4 Nov 2026, in USD

About FutureWorld

Its shares trade under the ticker FWDG. It has been listed since 21 June 2005. In the fiscal year to 31 March 2016, it reported revenue of $90,014 and a net loss of $1.5m. At that date it held total assets of $246,949 and shareholders' equity of −$633,417.

FutureWorld Corp. engages in identification, acquisition, development, and commercialization of hemp and cannabis products, services, and technologies. The company is headquartered in St. Petersburg, Florida. The company went IPO on 2005-06-21. The firm focuses on the identification, acquisition, development and commercialization of cannabis related products and services, such as industrial Hemp. The firm provides personal and professional tetrahydrocannabinoil (THC) and cannabidiol (CBD) test kits, pharmaceutical grade CBD oil solutions, SafeVape vaporizers, smart sensor technology, communication network, surveillance security, data analysis for smart cultivation, and consultation for the industrial hemp and legal medicinal cannabis. The firm's wireless agricultural smart sensor networks offer to the agriculture, irrigation systems and greenhouses for the global cannabis and hemp industry. The firm manufactures, markets, and sells products containing hemp derived CBD oil. The firm's subsidiaries include NutraCann Labs, Inc., URVape, Inc., HempTech Corp., FutureLand Corp. and Bioceudical Sciences.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
N/A
Industry
N/A
Listed since
21 Jun 2005

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • FutureWorld Corp. focuses on hemp and cannabis product development and commercialization.
  • NutraCann Labs and URVape subsidiaries enhance product diversity and market reach.
  • Smart sensor technology supports smart cultivation and data analysis in agriculture.

Weaknesses

  • FutureWorld Corp. relies on cannabis-related products which face regulatory challenges.
  • The company's focus on THC and CBD test kits may limit market expansion.
  • Subsidiaries like Bioceudical Sciences require significant investment.

Opportunities

  • Growing global demand for hemp and cannabis products presents market expansion.
  • The firm's smart sensor networks can be applied to broader agricultural sectors.
  • FutureWorld Corp. can leverage partnerships in the health care industry.

Threats

  • Regulatory changes in the US cannabis market could impact operations.
  • Competition from established pharmaceutical companies in CBD market.
  • Economic downturns may reduce consumer spending on discretionary cannabis products.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.